Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Hitchin, James"'
Autor:
Harris, William J., Huang, Xu, Lynch, James T., Spencer, Gary J., Hitchin, James R., Li, Yaoyong, Ciceri, Filippo, Blaser, Julian G., Greystoke, Brigit F., Jordan, Allan M., Miller, Crispin J., Ogilvie, Donald J., Somervaille, Tim C.P.
Publikováno v:
In Cancer Cell 17 April 2012 21(4):473-487
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maiques-Diaz, Alba, Spencer, Gary J., Lynch, James T., Ciceri, Filippo, Williams, Emma L., Amaral, Fabio M.R., Wiseman, Daniel H., Harris, William J., Li, Yaoyong, Sahoo, Sudhakar, Hitchin, James R., Mould, Daniel P., Fairweather, Emma E., Waszkowycz, Bohdan, Jordan, Allan M., Smith, Duncan L., Somervaille, Tim C.P.
Publikováno v:
Cell Reports, Vol 22, Iss 13, Pp 3641-3659 (2018)
Cell Reports
Cell Reports
Summary Pharmacologic inhibition of LSD1 promotes blast cell differentiation in acute myeloid leukemia (AML) with MLL translocations. The assumption has been that differentiation is induced through blockade of LSD1’s histone demethylase activity. H
Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores – a cautionary disclosure
Autor:
Acton, Ben, Small, Helen, Smith, Kate, Mcgonagle, Alison, Stowell, Alexandra, James, Dominic, Hamilton, Niall, Hamilton, Nicola, Hitchin, James, Hutton, Colin, Waddell, Ian, Ogilvie, Donald, Jordan, Allan
Publikováno v:
Acton, B, Small, H, Smith, K, Mcgonagle, A, Stowell, A, James, D, Hamilton, N, Hamilton, N, Hitchin, J, Hutton, C, Waddell, I, Ogilvie, D & Jordan, A 2019, ' Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores – a cautionary disclosure. ', Bioorganic and Medicinal Chemistry Letters, vol. 29, no. 4, pp. 560-562 . https://doi.org/83288294
Fluorination of metabolic hotspots in a molecule is a common medicinal chemistry strategy to improve in vivo half-life and exposure and, generally, this strategy offers significant benefits. Here, we report the application of this strategy to a serie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3818::cc53e563e40e23c76c0f8f5c720a4b1c
https://doi.org/83288294
https://doi.org/83288294
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jones, Stuart, Ahmet, Jonathan, Ayton, Kelly, Ball, Matthew, Cockerill, Mark, Fairweather, Emma, Hamilton, Nicola, Harper, Paul, Hitchin, James, Jordan, Allan, Levy, Colin, Lopez, Ruth, Mckenzie, Edward, Packer, Martin, Plant, Darren, Simpson, Iain, Simpson, Peter, Sinclair, Ian, Somervaille, Tim C P, Small, Helen, Spencer, Gary J, Thomson, Graeme, Tonge, Michael, Waddell, Ian, Walsh, Jarrod, Waszkowycz, Bohdan, Wigglesworth, Mark, Wiseman, Daniel H, Ogilvie, Donald
Publikováno v:
Jones, S, Ahmet, J, Ayton, K, Ball, M, Cockerill, M, Fairweather, E, Hamilton, N, Harper, P, Hitchin, J, Jordan, A, Levy, C, Lopez, R, Mckenzie, E, Packer, M, Plant, D, Simpson, I, Simpson, P, Sinclair, I, Somervaille, T C P, Small, H, Spencer, G J, Thomson, G, Tonge, M, Waddell, I, Walsh, J, Waszkowycz, B, Wigglesworth, M, Wiseman, D H & Ogilvie, D 2016, ' Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia Cells ', Journal of Medicinal Chemistry, vol. 59, no. 24, pp. 11120-11137 . https://doi.org/10.1021/acs.jmedchem.6b01320
A collaborative high throughput screen of 1.35 million compounds against mutant (R132H) isocitrate dehydrogenase IDH1 led to the identification of a novel series of inhibitors. Elucidation of the bound ligand crystal structure showed that the inhibit
Autor:
Shah, Pritom, Cheasty, Anne, Foxton, Caroline, Raynham, Tony, Farooq, Muddasar, Gutierrez, Irene Farre, Lejeune, Aurore, Pritchard, Michelle, Turnbull, Andrew, Pang, Leon, Owen, Paul, Boyd, Susan, Stowell, Alexandra, Jordan, Allan, Hamilton, Niall M., Hitchin, James R., Stockley, Martin, MacDonald, Ellen, Quesada, Mar Jimenez, Trivier, Elisabeth, Skeete, Jana, Ovaa, Huib, Moolenaar, Wouter H., Ryder, Hamish
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 15 November 2016 26(22):5403-5410
Autor:
James, Dominic, Smith, Kate, Jordan, Allan, Fairweather, Emma, Griffiths, Louise, Hamilton, Nicola, Hitchin, James, Hutton, Colin, Jones, Stuart, Kelly, Paul, Mcgonagle, Alison, Small, Helen, Stowell, Alexandra, Tucker, Julie, Waddell, Ian, Waszkowycz, Bohdan, Ogilvie, Donald
Publikováno v:
James, D, Smith, K, Jordan, A, Fairweather, E, Griffiths, L, Hamilton, N, Hitchin, J, Hutton, C, Jones, S, Kelly, P, Mcgonagle, A, Small, H, Stowell, A, Tucker, J, Waddell, I, Waszkowycz, B & Ogilvie, D 2016, ' First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib ', ACS chemical biology, vol. 11, no. 11, pp. 3179-3190 . https://doi.org/10.1021/acschembio.6b00609
The enzyme poly(ADP-ribose) glycohydrolase (PARG) performs a critical role in the repair of DNA single strand breaks (SSBs). However, a detailed understanding of its mechanism of action has been hampered by a lack of credible, cell-active chemical pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3818::b05924aac0197d0dbba5b5df73123c0c
https://research.manchester.ac.uk/en/publications/978c6aff-f49a-4af1-822e-e2e59f99fd27
https://research.manchester.ac.uk/en/publications/978c6aff-f49a-4af1-822e-e2e59f99fd27
Autor:
Finegan, Katherine G., Perez-Madrigal, Diana, Hitchin, James R., Davies, Clare, Jordan, Allan M., Tournier, Cathy
Chronic inflammation is a hallmark of many cancers, yet the pathogenic mechanisms that distinguish cancer-associated inflammation from benign persistent inflammation are still mainly unclear. Here we report that the protein kinase ERK5 controls the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6dce10b37e8b29e9602df2a76ce44d2e
https://europepmc.org/articles/PMC4333217/
https://europepmc.org/articles/PMC4333217/